B-19 Parvovirus Vaccine Study

NCT00379938 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Parvovirus B19 Infection

Interventions

BIOLOGICAL: VAI-VP705 (parvovirus B-19 vaccine)
DRUG: Placebo
BIOLOGICAL: MF-59

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)